Larrea Esther, Riezu-Boj José I, Gil-Guerrero Lucía, Casares Noelia, Aldabe Rafael, Sarobe Pablo, Civeira María P, Heeney Jonathan L, Rollier Christine, Verstrepen Babs, Wakita Takaji, Borrás-Cuesta Francisco, Lasarte Juan J, Prieto Jesús
Division of Gene Therapy and Hepatology, Center for Applied Medical Research, CIMA, Avenida Pío XII 55, 31008 Pamplona, Spain.
J Virol. 2007 Apr;81(7):3662-6. doi: 10.1128/JVI.02248-06. Epub 2007 Jan 17.
Indoleamine 2,3-dioxygenase (IDO) is induced by proinflammatory cytokines and by CTLA-4-expressing T cells and constitutes an important mediator of peripheral immune tolerance. In chronic hepatitis C, we found upregulation of IDO expression in the liver and an increased serum kynurenine/tryptophan ratio (a reflection of IDO activity). Huh7 cells supporting hepatitis C virus (HCV) replication expressed higher levels of IDO mRNA than noninfected cells when stimulated with gamma interferon or when cocultured with activated T cells. In infected chimpanzees, hepatic IDO expression decreased in animals that cured the infection, while it remained high in those that progressed to chronicity. For both patients and chimpanzees, hepatic expression of IDO and CTLA-4 correlated directly. Induction of IDO may dampen T-cell reactivity to viral antigens in chronic HCV infection.
吲哚胺2,3-双加氧酶(IDO)由促炎细胞因子和表达CTLA-4的T细胞诱导产生,是外周免疫耐受的重要介质。在慢性丙型肝炎中,我们发现肝脏中IDO表达上调,血清犬尿氨酸/色氨酸比值升高(反映IDO活性)。支持丙型肝炎病毒(HCV)复制的Huh7细胞在受到γ干扰素刺激或与活化T细胞共培养时,其IDO mRNA表达水平高于未感染细胞。在感染的黑猩猩中,治愈感染的动物肝脏IDO表达降低,而进展为慢性感染的动物肝脏IDO表达仍维持在较高水平。对于患者和黑猩猩而言,肝脏IDO和CTLA-4的表达直接相关。在慢性HCV感染中,IDO的诱导可能会抑制T细胞对病毒抗原的反应性。